Reckitt Benckiser Group (LON:RB) Given a GBX 5,300 Price Target at Royal Bank of Canada
Reckitt Benckiser Group (LON:RB) received a GBX 5,300 ($69.25) price objective from equities research analysts at Royal Bank of Canada in a report released on Wednesday, Borsen Zeitung reports. The firm presently has a “sell” rating on the stock. Royal Bank of Canada’s target price suggests a potential downside of 19.84% from the stock’s previous close.
A number of other equities analysts have also weighed in on the company. JPMorgan Chase & Co. set a GBX 9,000 ($117.60) target price on Reckitt Benckiser Group and gave the stock a “buy” rating in a research report on Wednesday. Shore Capital reaffirmed an “under review” rating on shares of Reckitt Benckiser Group in a research report on Wednesday. Liberum Capital reaffirmed a “buy” rating on shares of Reckitt Benckiser Group in a research report on Wednesday. Barclays reaffirmed an “overweight” rating on shares of Reckitt Benckiser Group in a research report on Wednesday, June 5th. Finally, Credit Suisse Group reaffirmed an “underperform” rating on shares of Reckitt Benckiser Group in a research report on Thursday, May 9th. Three research analysts have rated the stock with a sell rating, four have issued a hold rating and eleven have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of GBX 7,154.12 ($93.48).
Shares of Reckitt Benckiser Group stock traded up GBX 217 ($2.84) on Wednesday, reaching GBX 6,612 ($86.40). 1,541,033 shares of the company’s stock were exchanged, compared to its average volume of 1,720,000. The company has a debt-to-equity ratio of 80.49, a quick ratio of 0.47 and a current ratio of 0.65. Reckitt Benckiser Group has a 52 week low of GBX 5,559 ($72.64) and a 52 week high of GBX 7,174 ($93.74). The stock has a market capitalization of $46.60 billion and a price-to-earnings ratio of 21.69.
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
Featured Story: Google Finance Portfolio
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.